Schonfeld Strategic Advisors LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 68 filers reported holding OVID THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$34,000
-86.8%
10,100
-84.2%
0.00%
-100.0%
Q1 2021$257,000
+77.2%
64,000
+211.9%
0.00%
-72.7%
Q1 2018$145,000
-28.6%
20,5200.0%0.01%
-35.3%
Q4 2017$203,000
-29.3%
20,520
-38.7%
0.02%
-34.6%
Q3 2017$287,000
-21.8%
33,500
-4.3%
0.03%
-31.6%
Q2 2017$367,00035,0000.04%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders